Denali Therapeutics (DNLI) Insider Trading & Ownership → Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad) Free DNLI Stock Alerts $18.04 -0.86 (-4.55%) (As of 05/29/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Denali Therapeutics (NASDAQ:DNLI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.90%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$4.21 M Get DNLI Insider Trade Alerts Want to know when executives and insiders are buying or selling Denali Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DNLI Insider Buying and Selling by Quarter Ad The Freeport SocietyBiden Nomination CANCELED?The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here. Denali Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/15/2024Vicki L SatoDirectorSell1,666$18.29$30,471.14 4/1/2024Steve E KrognesDirectorSell92,500$20.50$1,896,250.00 2/15/2024Vicki L SatoDirectorSell1,666$18.37$30,604.42 2/13/2024Carole HoInsiderSell2,784$17.29$48,135.36 2/13/2024Ryan J WattsCEOSell9,589$17.29$165,793.81 2/13/2024Steve E KrognesDirectorSell2,750$17.29$47,547.50 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/16/2024Vicki L SatoDirectorSell1,666$18.42$30,687.72 1/10/2024Carole HoInsiderSell4,668$19.02$88,785.36 1/9/2024Ryan J WattsCEOSell7,818$19.78$154,640.04 1/5/2024Carole HoInsiderSell9,972$19.43$193,755.96 1/5/2024Ryan J WattsCEOSell17,483$19.43$339,694.69 1/5/2024Steve E KrognesDirectorSell3,208$19.43$62,331.44 12/15/2023Vicki L SatoDirectorSell1,666$23.39$38,967.74 11/15/2023Vicki L SatoDirectorSell1,666$19.13$31,870.58 10/16/2023Vicki L SatoDirectorSell1,666$20.66$34,419.56 9/15/2023Vicki L SatoDirectorSell1,666$23.62$39,350.92 8/23/2023Carole HoInsiderSell2,522$23.22$58,560.84 8/21/2023Carole HoInsiderSell2,478$22.60$56,002.80 8/21/2023Carole HoInsiderSell2,478$22.60$56,002.80 8/21/2023Ryan J WattsCEOSell2,309$22.59$52,160.31 8/21/2023Ryan J WattsCEOSell2,309$22.59$52,160.31 8/21/2023Steve E KrognesDirectorSell1,419$22.60$32,069.40 8/21/2023Steve E KrognesDirectorSell1,419$22.60$32,069.40 8/15/2023Vicki L SatoDirectorSell1,666$24.30$40,483.80 8/14/2023Carole HoInsiderSell2,768$23.79$65,850.72 8/10/2023Carole HoInsiderSell2,857$24.15$68,996.55 8/10/2023Ryan J WattsCEOSell2,526$25.03$63,225.78 7/17/2023Alexander O SchuthInsiderSell10,000$29.60$296,000.00 7/17/2023Vicki L SatoDirectorSell1,666$29.60$49,313.60 6/28/2023Vicki L SatoDirectorSell1,666$29.84$49,713.44 (Data available from 1/1/2013 forward) DNLI Insider Trading Activity - Frequently Asked Questions Who is on Denali Therapeutics's Insider Roster? The list of insiders at Denali Therapeutics includes Alexander O Schuth, Carole Ho, Marc Tessier-Lavigne, Ryan J Watts, Steve E Krognes, Vicki L Sato. Learn more on insiders at DNLI. What percentage of Denali Therapeutics stock is owned by insiders? 7.90% of Denali Therapeutics stock is owned by insiders. Learn more on DNLI's insider holdings. Which Denali Therapeutics insiders have been selling company stock? The following insiders have sold DNLI shares in the last 24 months: Alexander O Schuth ($1,090,628.80), Carole Ho ($1,028,376.05), Marc Tessier-Lavigne ($2,834,589.60), Ryan J Watts ($2,801,674.19), Steve E Krognes ($2,335,882.86), and Vicki L Sato ($375,882.92). How much insider selling is happening at Denali Therapeutics? Insiders have sold a total of 405,244 Denali Therapeutics shares in the last 24 months for a total of $10,467,034.42 sold. More Insider Trading Tools from MarketBeat Related Companies: PRTA Insider Ownership RGNX Insider Ownership CYTK Insider Ownership RGEN Insider Ownership PCVX Insider Ownership RVMD Insider Ownership EXEL Insider Ownership HALO Insider Ownership CRSP Insider Ownership KRYS Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month This page (NASDAQ:DNLI) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceThe 7th Trillion Dollar Company?The Oxford ClubThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBiden Nomination CANCELED?The Freeport SocietyBUY ALERT: Tiny tech play partners with US governmentStansberry ResearchGold Set to EXPLODE!Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Denali Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.